Condition: Thromboembolism · Sponsor: University of Arkansas
Subjects with thromboembolic disease or at high-risk for thromboembolic conditions diagnosed with ultrasound or other standard of care techniques will be recruited to estimate the feasibility of a device to detect in vivo CBCs.
This description comes directly from the study's public registry record.
Sanjeeva Onteddu, MD · 5016865135 · sronteddu@uams.edu
Always discuss trial participation with your own doctor first.
| Univerisity of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05301348